We’re still waiting on DEA to issue Dr. Mithoefer his Schedule I license. DEA claims it is waiting to hear from FDA regarding a requested consultation about Dr. Mithoefer’s qualifications to conduct research. We’ve inquired at FDA to determine whether DEA’s request for consultation has actually arrived yet and, if so, when FDA will reply. We expect to hear back from FDA shortly. According to the Code of Federal Regulations, DEA must issue a Schedule I license for FDA-approved research within 10 days of receiving favorable recommendation from FDA unless the applicant has lied on his application, has had a drug-related felony conviction, or no longer licensed by the State. Since Dr. Mithoefer cannot be refused his license on any of these grounds, we’re cautiously optimistic we will be able to start the study shortly after FDA responds to DEA’s request for consultation.